Looking for volunteers
Transanal Total Mesorectal Excision vs Robotic Total Mesorectal Excision
NCT07651553 · Sun Yat-sen University · Updated 16 June 2026
- What is being tested
- robotic surgery vs transanal total mesorectal excsion
- For
- Rectal Cancer Patients; Robotic Assisted Intervention
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 75 years. About 216 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started 30 June 2025, ends 28 April 2029. Registered 16 June 2026.
- Results
- None posted yet.
In the researchers' words
TME remains standard treatment for rectal cancer. Both Robotic TME and taTME are innovative surgical techniques with potential advantages in low rectal cancer. To date, no clinical studies have directly compared the conversion and complication rates between taTME and RTME in this population. Therefore, the investigators propose to conduct a prospective, randomized, parallel-controlled clinical trial comparing taTME with RTME for low rectal cancer, aiming to provide high-level evidence for surgical decision-making and benefit more patients.
Sites
- the sixth affiliated hospital of Sun Yat-sen UniversityGuangzhou, Guangdong, China